Skyscape Web Viewer : The Maudsley Deprescribing Guidelines: Antidepressants, Benzodiazepines, Gabapentinoids and Z-drugs : Main Index

View All
Education, withdrawal symptoms management
Electric shock antidepressant withdrawal benzodiazepines and z-drug withdrawal 317 Further Topics
Emotional anaesthesia/numbing, withdrawal symptoms
Empirical support gradual tapering hyperbolic tapering
Endocrine function
Environmental stimuli
Epilepsy Switching to Longer-Acting Benzodiazepines to Taper When and Why to Stop Benzodiazepines and Z-Drugs When and Why to Stop Gabapentinoids
Escitalopram Escitalopram Factors Influencing Development of Withdrawal Effects Managing Complications of Antidepressant Discontinuation Practical Options in Prescribing Gradually Tapering Doses of Antidepressants Tapering Antidepressants Gradually
Estazolam Estazolam Switching to Longer-Acting Benzodiazepines to Taper
Eszopiclone Eszopiclone Switching to Longer-Acting Benzodiazepines to Taper
Extending dosing intervals antidepressants benzodiazepines and z-drugs every-other-day dosing gabapentinoids
Facilitators to deprescribing antidepressants Barriers and Facilitators to Deprescribing gabapentinoids Tapering Psychiatric Drugs in Practice
Fear regarding withdrawal antidepressants Barriers and Facilitators to Deprescribing benzodiazepines and z-drugs gabapentinoids Tapering Psychiatric Drugs in Practice
Fluoxetine, Factors Influencing Development of Withdrawal Effects Stratfiying Risk of Antidepressant Withdrawal
Flurazepam Flurazepam Nitrazepam Switching to Longer-Acting Benzodiazepines to Taper
Fluvoxamine Factors Influencing Development of Withdrawal Effects Fluvoxamine Practical Options in Prescribing Gradually Tapering Doses of Antidepressants
Gabapentin Overview of Gabapentinoid Withdrawal Effects Principles for Tapering Gabapentinoids When and Why to Stop Gabapentinoids
Gabapentinoids
Gastrointestinal withdrawal effects/ symptoms antidepressants benzodiazepines and z-drugs gabapentinoids
Generalised anxiety disorder When and Why to Stop Antidepressants When and Why to Stop Benzodiazepines and Z-Drugs When and Why to Stop Gabapentinoids
General Medical Council (GMC) guidance Making Up Smaller Doses of Benzodiazepines and Z-Drugs Practically Making Up Smaller Doses of Gabapentinoids Practically Practical Options for Prescribing Gradually Tapering Doses Practical Options in Prescribing Gradually Tapering Doses of Antidepressants
Gradual tapering antidepressants benzodiazepines and z-drugs Further Topics gabapentinoids The Neurobiology of Tapering
Hamilton Anxiety Rating Scale (HAM-A) When and Why to Stop Antidepressants When and Why to Stop Benzodiazepines and Z-Drugs When and Why to Stop Gabapentinoids
Harms of tapering
Harms outweighing benefits
High dose prescribing
Homeostatic adaptation Pathophysiology of Antidepressant Withdrawal Symptoms Pathophysiology of Psychiatric Drug Withdrawal Symptoms
Homeostatic disruption Pathophysiology of Antidepressant Withdrawal Symptoms Pathophysiology of Psychiatric Drug Withdrawal Symptoms The Neurobiology of Tapering
Hyperbolic tapering antidepressants benzodiazepines and z-drugs gabapentinoids theoretical aspects
Hypnotic effects antidepressants benzodiazepines and z-drugs